Portable and Wearable Medical Devices: A Nanotechnology Approach

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Point-of-care testing (POCT) is destined to play a much greater role in chronic disease diagnosis and management. Advanced POCT systems are being developed to deliver less costly and more acute healthcare in a patient’s home, but remain scarce. Especially lacking are miniature devices, similar to the commonly used blood glucose meter, to quantitatively detect low concentrations of protein biomarkers in blood. Here, a unique integrated system solution is presented, which represents a significant step beyond proof-of-concept high sensitivity nanosensors, for quantitative reading of b-type natriuretic peptide (BNP) in outpatient blood. BNP is an established biomarker for early heart failure (HF) diagnosis and prognosis. HF is an epidemic affecting more than 26 million people worldwide and a chronic disease with ever increasing prevalence. Currently, accurate and quantitative BNP blood tests are only available in central laboratory and emergency room using venous blood. Highly sensitive carbon nanotube thin film (CNT-TF) impedance sensors are integrated into a user-friendly POCT system, NanoBot, which consists of two parts: a disposable test strip and a miniature electrical readout unit. Using electrochemical impedance spectroscopy (EIS), combined with standard addition, NanoBot is demonstrated to detect blood BNP with a limit of detection (LOD), precision, and accuracy comparable to those of a standard immunofluorescence assay (IFA) and a commercial emergency room POCT device. A pilot clinical study with patient-derived blood plasma validates that NanoBot has not only strong performance, but also other advantages such as low sample volume, label-free and wash-free detection. Collectively, NanoBot’s performance and operational characteristics signify its promising potential as a POCT device for home-use heart failure diagnosis.

Learning Objectives:

1. Various aspects of electrochemical immunosensors for high-sensitivity detection of protein biomarkers

2. Recent advances and challenges in developing nano-biosensors

3. The need for disruptive technology to make the change from centralized healthcare to distributed healthcare


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
Loading Comments...
Show Resources